T-cell

(redirected from T-cells)
Also found in: Thesaurus, Medical, Encyclopedia.
Related to T-cells: Cytokines, B-cells

T-cell

n
(Biochemistry) another name for T-lymphocyte
References in periodicals archive ?
Cellectis a clinical-stage biopharmaceutical company focused on developing immunotherapies based on gene-edited allogeneic CAR T-cells (UCART), announced today the issuance of two U.
The company's TriTAC molecules are half-life extended and designed to simultaneously bind to cancer cells and T-cells, triggering those T-cells to attack the targeted cancer cells.
Recent research has identified a novel subset of T-cells that are responsible for driving autoantibody production in the synovium by B-cells.
The role of mammalian target of rapamycin (mTOR), T-box expressed in T-cells (T-bet), and eomesodermin (EOMES) in mediating T lymphocytes differentiation in response to Aspergillus fumigatus infection in immunocompromised rats was investigated in this study.
Scientists have previously shown that killer T-cells, a type of white blood cell that normally protects us from germs, play a major part in type 1 diabetes by destroying insulin producing cells, known as beta cells.
The "stem memory" T-cells would keep patrolling the body looking out for enemy tumour cells.
In the US trial, white blood cells - known as T-cells - were taken from patients suffering acute lymphoblastic leukaemia and genetically modified to target the cancer.
Targeting cancer using T-cells is a growing therapeutic area but they are limited in their cancer-fighting potential because of their inability to attack the body's own tissue.
According to NIAID, the lack of memory T-cells in babies can make the virus vulnerable against drugs due to lack of reservoirs.
Millions of T-cells were taken out from the patient's blood and grown in the laboratory until the doctors had billions of cells, the BBC reported.
Bluebird Bio has entered a strategic collaboration with Celgene to discover, develop and commercialize disease-altering gene therapies in oncology focused on genetically modifying T-cells, known as chimeric antigen receptor (CAR) T-cells, to target and destroy cancer cells.
Both the stem cells for transplant and the T-cells came from the same matched donors.